Neuroendocrine tumors of the larynx: A clinical report and literature review

Tumori

Volumn 92, Issue 1, 2006, Pages 72-75

  Procopio, Giuseppe ^a   Ricotta, Riccardo ^a   Fusi, Alberto ^a   Celio, Luigi ^a   De Dosso, Sara ^a   Catena, Laura ^a   Ferrari, Leonardo ^a   Quattrone, Pasquale ^a   Verzoni, Elena ^a   Bajetta, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Carcinoids; Chemotherapy; Larynx; Neuroendocrine tumors

Indexed keywords

CAPECITABINE; OXALIPLATIN;

AGED; ANAMNESIS; CANCER GROWTH; CANCER INCIDENCE; CANCER RELAPSE; CARCINOID; CASE REPORT; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; DRUG TOLERABILITY; DYSPHONIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; JAW DISEASE; LABORATORY TEST; LARYNX TUMOR; LOW LEVEL LASER THERAPY; LYMPHADENOPATHY; MALE; MEDICAL LITERATURE; METASTASIS; MICROLARYNGOSCOPY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; REVIEW;

EID: 33645972913     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200112     Document Type: Review

References (25)

1. Goldman NC, Hood CI, Singleton GP: Carcinoid of the larynx. Arch Otolaryngol, 90: 64-67, 1969.
2. Alujevic A, Juric G, Separovic R, Kruslin B: Unusual features of metastatic atypical carcinoid of the larynx. Eur Arch Otorhinolaryngol, 255: 318-321, 1998.
3. Soga J, Osaka M, Yakuwa Y: Laryngeal endocrinomas (carcinoids and relevant neoplasms): analysis of 278 reported cases. J Exp Clin Cancer Res, 21: 5-13, 2002.
4. Mills SE: Neuroendocrine tumors of the head and neck: a selected review with emphasis on terminology. Endocr Pathol, 7: 329-343, 1996.
5. Vallejo Valdezate LA, Menendez Arguelles ME, Diaz Suarez I, Gil-Carcedo Sanudo E, Cuetos Azcona M, Gil-Carcedo Garcia LM, Sanz Santacruz C: Small-cell laryngeal neuroendocrine carcinoma. A case report and review of literature. An Otorinolaringol Ibero Am, 29: 505-514, 2002.
6. Kasantikul V, Keelawat S, Maneesri S, Panichabhongse V: Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx. J Med Assoc Thai, 80: 396-401, 1997.
7. Machens A, Holzhausen HJ, Dralle H: Minimally invasive surgery for recurrent neuroendocrine carcinoma of the supraglottic larynx. Eur Arch Otorhinolaryngol, 256: 242-246, 1999.
8. Wenig M, Gnepp DR: The spectrum of neuroendocrine carcinomas of the larynx. Semin Diagn Pathol, 6: 329-350, 1989.
9. Woodruff JM, Senie RT: Atypical carcinoid tumor of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec, 53: 194-209, 1991.
10. Ferlito A, Barnes L, Rinaldo A, Gnepp DR, Milroy CM: A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment. J Laryngol Otol, 112: 827-834, 1998.
11. Ferlito A, Friedmann I: Review of neuroendocrine carcinomas of the larynx. Ann Otol Rhinol Laryngol, 98: 780-790, 1989.
12. Wenig BM, Hyams VJ, Heffner DK: Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases. Cancer, 62: 2658-2676, 1988.
13. Kim KM, Choi EC, Hong WP, Jeong HJ: Primary carcinoid tumor of the larynx. Yonsey Med J, 30: 193-197, 1989.
14. Mills SE: Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol, 15: 264-278, 2002.
15. Milroy CM, Rode J, Moss E: Laryngeal paragangliomas and neuroendocrine carcinomas. Histopathology, 18: 201-209, 1991.
16. Govaerts PJ, van den Broek P, Corstens FH, Peters HM: Clinical oncology: case presentations from oncology centres-2. Carcinoid of the larynx. Eur J Cancer, 28: 1755-1758, 1992.
17. Kau R, Arnold W: Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck. Acta Otolaryngol, 116: 345-349, 1996.
18. Brisigotti M, Fabbretti G, Lanzanova G, Brugnari ER, Presutti L, Artoni S: Atypical carcinoid of the larynx: case report. Tumori, 73: 417-421, 1987.
19. Dictor M, Tennvall J, Akerman M: Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the supraglottic larynx. A report of two cases including immunohistochemistry and aspiration cytology. Arch Pathol Lab Med, 116: 253-257, 1992.
20. Moisa II: Neuroendocrine tumors of the larynx. Head Neck, 13: 498-508, 1991.
21. Ferlito A, Shaha AR, Rinaldo A: Neuroendocrine neoplasms of the larynx: diagnosis, treatment and prognosis. ORL J Otorhinolaryngol Relat Spec, 64: 108-113, 2002.
22. Shemen L, Petratos P, Patel S, Horowitz L: Infiltrating, moderately differentiated neuroendocrine tumor of the larynx: a brief report. Ear Nose Throat J, 82: 205-207, 2003.
23. Maisel R, Schmidt D, Pambuccian S: Subglottic laryngeal paraganglioma. Laryngoscope, 113: 401-405, 2003.
24. Catena L, Bajetta E, Procopio G, Ferrari L, Della Torre S, Verzoni E, Bichisao E, Buzzoni R, Iacobelli S, Falcone G: Oxaliplatin plus capecitabine in advanced neuroendocrine tumours (NETs): is the new WHO classification applicable to daily practice? Eur J Cancer, 1: 540 (abstract 117), 2003.
25. Bajetta E, Procopio G, Ferrari L, Catena L, Del Vecchio M, Bombardieri E: Update on the treatment of neuroendocrine tumors. Expert Rev Anticancer Ther, 3: 631-642, 2003.